136 related articles for article (PubMed ID: 3510945)
21. Evaluation of whole abdominal irradiation in ovarian carcinoma with a four orthogonal fields technique.
Thomas L; Pigneux J; Chauvergne J; Stöckle E; Bussières E; Chemin A; Toulouse C
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1083-90. PubMed ID: 7961015
[TBL] [Abstract][Full Text] [Related]
22. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
[TBL] [Abstract][Full Text] [Related]
23. Post-operative chemotherapy for ovarian carcinoma: a prospective study with cyclophosphamide.
Akinkugbe A; Uguru VE; Mordi VP
Int J Gynaecol Obstet; 1985 Dec; 23(6):499-504. PubMed ID: 2868945
[TBL] [Abstract][Full Text] [Related]
24. Therapy of ovarian carcinoma: the relationship of dose level and treatment intensity to survival.
Jacobs AJ; Sommers GM; Homan SM; Camel HM; Axelrod JH; Kao MS; Galakatos AE; Parham J; Lippmann L
Gynecol Oncol; 1988 Sep; 31(1):233-47. PubMed ID: 3410352
[TBL] [Abstract][Full Text] [Related]
25. Abdominopelvic radiation for stage I-II ovarian cancer. The effect of grade on outcome.
Hart S; Ben-Baruch G; Herczeg E; Hertzberg A; Modan M; Menczer J
Eur J Gynaecol Oncol; 1989; 10(6):416-20. PubMed ID: 2627973
[TBL] [Abstract][Full Text] [Related]
26. Clinical implication of medroxyprogesterone acetate against advanced ovarian carcinoma: a pilot study.
Niwa K; Onogi K; Wu Y; Mori H; Harrigan RC; Tamaya T
Eur J Gynaecol Oncol; 2008; 29(3):252-5. PubMed ID: 18592789
[TBL] [Abstract][Full Text] [Related]
27. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy.
Kapp KS; Kapp DS; Poschauko J; Stücklschweiger GF; Hackl A; Pickel H; Petru E; Winter R
Gynecol Oncol; 1999 Sep; 74(3):400-7. PubMed ID: 10479500
[TBL] [Abstract][Full Text] [Related]
28. Primary treatment of stage III ovarian carcinoma with sequential chemotherapy and whole abdominal radiation therapy.
Reid GC; Roberts JA; Hopkins MP; Schoeppel SL; Perez-Tamayo C; Drescher C; Chamberlain D; Morley GW
Gynecol Oncol; 1993 Jun; 49(3):333-8. PubMed ID: 8314535
[TBL] [Abstract][Full Text] [Related]
29. Advanced ovarian cancer: primary treatment with surgery, radiotherapy, and chemotherapy.
Griffiths CT; Grogan RH; Hall TC
Cancer; 1972 Jan; 29(1):1-7. PubMed ID: 5007381
[No Abstract] [Full Text] [Related]
30. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
31. Current management of epithelial carcinoma of the ovary.
Zucker PK; Rosenshein NB
Compr Ther; 1985 May; 11(5):52-9. PubMed ID: 4006423
[No Abstract] [Full Text] [Related]
32. [Technic, indications and radiobiological limits of the moving strip treatment of patients with stage III ovarian carcinoma already treated with surgery and chemotherapy].
Micheletti E; Morrica B
Radiol Med; 1983 Sep; 69(9):667-71. PubMed ID: 6687014
[TBL] [Abstract][Full Text] [Related]
33. Hyperfractionation of whole-abdomen radiation therapy: salvage treatment of persistent ovarian carcinoma following chemotherapy.
Morgan L; Chafe W; Mendenhall W; Marcus R
Gynecol Oncol; 1988 Sep; 31(1):122-36. PubMed ID: 3410343
[TBL] [Abstract][Full Text] [Related]
34. [Surgery in the treatment concept of epithelial ovarian cancer].
Salzer H; Genger H; Gober S; Barrada M; Vavra N; Sevelda P
Gynakol Rundsch; 1990; 30 Suppl 1():26-9. PubMed ID: 2079293
[No Abstract] [Full Text] [Related]
35. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line.
Siler DF; Wheeless CR; Dubin NH
Cancer; 1996 May; 77(9):1850-3. PubMed ID: 8646684
[TBL] [Abstract][Full Text] [Related]
37. [Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer].
Sevelda P; Kurz C; Obermair A; Vavra N; Breitenecker G; Czerwenka K; Dittrich C; Salzer H
Wien Klin Wochenschr; 1993; 105(24):732-6. PubMed ID: 8116312
[TBL] [Abstract][Full Text] [Related]
38. A pilot study of three-cycle consolidation chemotherapy with paclitaxel and platinum in epithelial ovarian cancer patients with clinical complete response after paclitaxel and platinum chemotherapy.
Lee SJ; Lee JW; Min JA; Park CS; Kim BG; Lee JH; Bae DS
Int J Gynecol Cancer; 2006; 16(1):95-100. PubMed ID: 16445617
[TBL] [Abstract][Full Text] [Related]
39. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
Alberts DS; Liu PY; Hannigan EV; O'Toole R; Williams SD; Young JA; Franklin EW; Clarke-Pearson DL; Malviya VK; DuBeshter B
N Engl J Med; 1996 Dec; 335(26):1950-5. PubMed ID: 8960474
[TBL] [Abstract][Full Text] [Related]
40. [Stage III and IV epithelial cancer of the ovary. Prognostic role of surgical tumor reduction].
Le Bouedec G; Ben Ahmed S; Plagne R; Dauplat J
Presse Med; 1990 Mar; 19(11):506-10. PubMed ID: 2138748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
